National Institutes of Health
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing November 2, 2028.
Overview
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials,…